Specifically, the hypomagnesemia resolved when the PPI was replaced by a histamine H2-receptor antagonist; recurrence of the hypomagnesemia was seen if the PPI was restarted; and the hypomagnesemia caused severe symptoms in some patients [324,325]. This evidence concerns the gene HRH2 and Hypomagnesemia.